Fundraising FoxICURe
AcceleratorPre-Seed · 1 people tracked
Find your way into ICURe
Sign up to find every way you can get introduced to ICURe
- Your email: who you already know at ICURe, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ICURe team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
ICURe is a UK-based accelerator program aimed at academic researchers exploring the commercial potential of their work. It supports participants in testing and validating whether their research can form the basis of a viable business.
Team · 1 people
from public directoriesPortfolio companies · 1 tracked
alumni founders can tell you what the program is really likeOther
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CGEN Engineering
Frequently asked questions
- What stage does ICURe invest at?
- ICURe invests at the Pre-Seed stage.
- What sectors does ICURe focus on?
- ICURe focuses on Deep Tech.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Blueyard is a small equal partnership with offices in the US and Europe, investing in early-stage companies.